Lamia Kalfane currently holds the position of Country Head Medical Affairs at Novocure, a role commenced in March 2023. Previously, Lamia served as the Therapeutic Area Head for the Cardiovascular, Renal, Metabolism, and Respiratory Franchise and as MSL Manager at Novartis from 2018 to 2022. Prior experience includes serving as Associate Director of Medical Science Liaison at Taiho Pharma Canada Inc from 2017 to 2018 and as a Medical Advisor in Oncology at Pfizer from 2008 to 2017. Early in the career, Lamia was a Clinical Pharmacy Manager at Mount Sinai St. Luke's and Mount Sinai Roosevelt from 2000 to 2005, where the Oncology Pharmacy was established and led. Educational qualifications include a Doctor of Pharmacy (PharmD) from Oregon Health & Science University and a Bachelor of Pharmacy (BPharm) from The University of British Columbia.